A dementia-focused VC digs past amyloid for new kinds of brain drugs
BioPharma
Stay updated with breaking news from Jonathan Behr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV)Round led by the DDF (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and fo...